Marpai (MRAI) Short Interest Ratio & Short Volume

Short interest is the volume of Marpai shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 11,500 shares of MRAI short. 0.22% of Marpai's shares are currently sold short. Learn More on Marpai's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.22% of Marpai's floating shares are currently sold short.

Marpai saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 11,500 shares, a drop of 84.7% from the previous total of 75,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Marpai currently has issued a total of 13,740,000 shares. Some of Marpai's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Marpai currently has a public float of 5,130,000 shares.

0.22% of Marpai's shares are currently sold short. Here is how the short interest of companies compare to Marpai: Concord Medical Services Holdings Limited (0.48%), Burning Rock Biotech Limited (1.42%), ATI Physical Therapy, Inc. (0.77%), The Oncology Institute, Inc. (0.76%), Renalytix Plc (0.46%), Psychemedics Co. (0.55%), BioRestorative Therapies, Inc. (0.91%), Ontrak, Inc. (8.33%), BioNexus Gene Lab Corp. (0.87%), Kindly MD, Inc. (5.84%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

Short selling MRAI is an investing strategy that aims to generate trading profit from Marpai as its price is falling. MRAI shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Marpai occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRAI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRAI, twice per month. The most recent reporting period available is May, 15 2024.